Chemi S.p.A.   Report issue

For profit Phase 1 Phase 2
Founded: Cinisello Balsamo Italy (1973)
Status: No NME R&D (1973)

Organization Overview

First Clinical Trial
2012
NCT01754285
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

octreotide (sandostatin) (2 trials)

Drugs in Phase 1 Trials (1)

enoxaparin (lovenox) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Seroma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2